ID

13747

Descrizione

The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01065545

collegamento

https://clinicaltrials.gov/show/NCT01065545

Keywords

versioni (1)
  1. 02/03/16 02/03/16 -
Titolare del copyright

CC BY-NC 3.0

Caricato su

2 marzo 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Acute Myeloid Leukemia NCT01065545

Inglese

Eligibility Acute Myeloid Leukemia NCT01065545

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of acute myeloid leukemia, in first or second remission.
Descrizione

diagnosis of acute myeloid leukemia, in first or second remission.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0544452
UMLS CUI [1,3]
C0205435
UMLS CUI [2,1]
C0023467
UMLS CUI [2,2]
C0544452
UMLS CUI [2,3]
C0205436
age 55 or older
Descrizione

age 55 or older

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
patients must have given signed, informed consent prior to registration on study.
Descrizione

patients must have given signed, informed consent prior to registration on study.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
participants must have attained a complete remission (cr) to induction chemotherapy and are not good candidates for further intensive chemotherapy or a transplant.
Descrizione

participants must have attained a complete remission (cr) to induction chemotherapy and are not good candidates for further intensive chemotherapy or a transplant.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0677874
female patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to enrollment.
Descrizione

female patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to enrollment.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0032976
male and female patients must use an effective contraceptive method during the study and for a minimum of 6 months after study treatment.
Descrizione

male and female patients must use an effective contraceptive method during the study and for a minimum of 6 months after study treatment.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0449238
UMLS CUI [1,2]
C0032976
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with a diagnosis of acute promyelocytic leukemia are not eligible.
Descrizione

patients with a diagnosis of acute promyelocytic leukemia are not eligible.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023487
participants cannot be currently receiving chemotherapy, radiation therapy, or immunotherapy.
Descrizione

participants cannot be currently receiving chemotherapy, radiation therapy, or immunotherapy.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205420
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0205420
UMLS CUI [3,1]
C0021083
UMLS CUI [3,2]
C0205420
patients must not be receiving any other investigational agents.
Descrizione

patients must not be receiving any other investigational agents.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1875319
participants cannot have hepatitis b or c or hiv.
Descrizione

participants cannot have hepatitis b or c or hiv.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0019682
UMLS CUI [1,2]
C0019163
UMLS CUI [1,3]
C0019196
patients must not have an uncontrolled infection
Descrizione

patients must not have an uncontrolled infection

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009450
Ritorna all'inizio della pagina

Similar models

Eligibility Acute Myeloid Leukemia NCT01065545

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
AML in first or second remission
Item
diagnosis of acute myeloid leukemia, in first or second remission.
boolean
C0023467 (UMLS CUI [1,1])
C0544452 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0023467 (UMLS CUI [2,1])
C0544452 (UMLS CUI [2,2])
C0205436 (UMLS CUI [2,3])
age
Item
age 55 or older
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
patients must have given signed, informed consent prior to registration on study.
boolean
C0021430 (UMLS CUI [1])
complete remission
Item
participants must have attained a complete remission (cr) to induction chemotherapy and are not good candidates for further intensive chemotherapy or a transplant.
boolean
C0677874 (UMLS CUI [1])
childbearing potential negative pregnancy test
Item
female patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to enrollment.
boolean
C3831118 (UMLS CUI [1])
C0032976 (UMLS CUI [2])
contraception duration
Item
male and female patients must use an effective contraceptive method during the study and for a minimum of 6 months after study treatment.
boolean
C0449238 (UMLS CUI [1,1])
C0032976 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
APL
Item
patients with a diagnosis of acute promyelocytic leukemia are not eligible.
boolean
C0023487 (UMLS CUI [1])
concurrent therapy
Item
participants cannot be currently receiving chemotherapy, radiation therapy, or immunotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0205420 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3,1])
C0205420 (UMLS CUI [3,2])
investigational agents
Item
patients must not be receiving any other investigational agents.
boolean
C1875319 (UMLS CUI [1])
hiv, hepatitis b or c
Item
participants cannot have hepatitis b or c or hiv.
boolean
C0019682 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
infection
Item
patients must not have an uncontrolled infection
boolean
C0009450 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial